| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 29.437 | 27.565 | 29.117 | 46.403 | 61.552 | 61.570 | 62.116 | 63.656 | 71.890 | 76.083 |
| Total Income - EUR | 29.478 | 27.610 | 29.134 | 46.403 | 62.091 | 65.943 | 62.173 | 64.023 | 72.055 | 76.101 |
| Total Expenses - EUR | 25.225 | 22.236 | 19.567 | 22.285 | 27.991 | 38.796 | 34.295 | 32.985 | 37.308 | 42.055 |
| Gross Profit/Loss - EUR | 4.253 | 5.374 | 9.567 | 24.118 | 34.101 | 27.148 | 27.878 | 31.038 | 34.747 | 34.046 |
| Net Profit/Loss - EUR | 3.369 | 4.822 | 7.052 | 23.654 | 33.482 | 26.578 | 27.332 | 30.414 | 34.135 | 31.809 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 2 |
Check the financial reports for the company - Cabinet Medical Dr. Dan Lascăr Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 16.079 | 15.103 | 13.675 | 12.553 | 47.755 | 37.842 | 28.666 | 21.295 | 7.882 | 1.986 |
| Current Assets | 87.152 | 45.263 | 52.413 | 70.107 | 88.532 | 55.963 | 72.203 | 47.338 | 72.025 | 56.796 |
| Inventories | 0 | 0 | 872 | 856 | 839 | 823 | 805 | 807 | 805 | 801 |
| Receivables | 74.727 | 35.392 | 34.545 | 66.181 | 85.730 | 51.606 | 70.189 | 45.707 | 68.667 | 53.037 |
| Cash | 12.425 | 9.871 | 16.996 | 3.070 | 1.963 | 3.534 | 1.209 | 823 | 2.553 | 2.958 |
| Shareholders Funds | 21.519 | 26.121 | 32.016 | 50.785 | 74.817 | 42.090 | 57.370 | 30.333 | 52.596 | 38.879 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 81.712 | 34.245 | 34.072 | 31.876 | 61.470 | 51.786 | 43.570 | 38.462 | 27.402 | 19.902 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Cabinet Medical Dr. Dan Lascăr Srl